Sign in

Thomas Tu

@thatliverguy.bsky.social
693 followers 2.1K following 4 posts

A/Prof in Sydney (WIMR), living with hep B, dedicated to kicking Hepatitis B Virus butt (he/his/him)

PostsRepliesMedia
Reposted by Thomas Tu
Hepatitis Australia @hepatitisaustralia.bsky.social · 07/05/2025
In this conversation with Rich Condit, Thomas Tu (@thatliverguy.bsky.social) shares his journey with Hep B from diagnosis to dedicating his career to finding answers, and opens up about the science, the stigma, and his experience. 📺 Watch now: www.youtube.com/watch?v=5LM8...
youtube.com
TWiV Special: A Shot of Hep B with Thomas Tu
YouTube video by MicrobeTV
041
Reposted by Thomas Tu
Rowena Bull @robull.bsky.social · 14/03/2025
Registration now open for HCV-Flavi 2025!
0108
Reposted by Thomas Tu
The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 04/02/2025
New research - Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial tinyurl.com/4cvdy6h2 #LiverSky #IDSky #MedSky #HepSky
2134
Reposted by Thomas Tu
HepB Cant Wait @suwang88.bsky.social · 22/12/2024
Superb piece on #HBV by in the New Yorker by @ingfeichen.bsky.social! She does a great job covering so many important aspects of #HepatitisB. Hoping this article brings much needed awareness to #HepB! www.newyorker.com/science/anna...
newyorker.com
A Cancer-Causing Virus Hiding in Millions of Americans
Why does hepatitis B, which can lead to liver cancer, often go undetected, even though tests exist?
184
Reposted by Thomas Tu
Rob Brierley @robbrierley.bsky.social · 18/12/2024
New Comment - Freeland et al - The urgent need to end hepatitis B stigma and discrimination www.thelancet.com/journals/lan... #LiverSky #HepSky #IDSky
thelancet.com
The urgent need to end hepatitis B stigma and discrimination
More than 250 million people live with chronic hepatitis B, making it the most common chronic infection worldwide.1 Despite effective tools to prevent transmission, diagnosis, and treatment, hepatitis B is the leading cause of liver cancer globally, with two people dying every minute and little change in hepatitis B mortality in the past 20 years.1 Globally, only 13% of people with hepatitis B are aware of their infection and access to treatment and care is scarce, particularly in low-income and middle-income countries.
082
Reposted by Thomas Tu
Rob Brierley @robbrierley.bsky.social · 14/12/2024
New Comment - Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families www.thelancet.com/journals/lan... @pippa-matt.bsky.social #HepSky #IDSky #LiverSky #MedSky
2164
Reposted by Thomas Tu
Australasian Virology Society @ausvirologysoc.bsky.social · 04/12/2024
Last up is a prerecorded presentation from Dong Li (Westmead) with @thatliverguy.bsky.social who is Investigating HBV DNA integration and its role in genomic instability through HBx expression (Poster #116) And that finishes up the second Science Bites session, let’s go for tea! #AVS12
041
Reposted by Thomas Tu
Rob Brierley @robbrierley.bsky.social · 13/11/2024
Globally, only 13% of people living with chronic hepatitis B & 36% living with chronic hepatitis C have been diagnosed. It’s time for World Hepatitis Testing Week. New Comment from the World Hepatitis Alliance: www.thelancet.com/journals/lan... #GastroSky #NoHep
thelancet.com
It is time for World Hepatitis Testing Week
Undiagnosed hepatitis B and C is driving a global health crisis, contributing to more than a million deaths each year from cancer and other liver diseases.1 Globally, only 13% of people living with ch...
0146